In all 5 studies, administration of IVIG in the clindamycin-treated subgroup was associated with lower mortality rates, but it did not reach statistical significance in isolation in any of the studies ( Figure 1 ; Supplementary Table 6 ).
← all excerpts
Polyspecific Intravenous Immunoglobulin in Clindamycin-treated Patients With Streptococcal Toxic Shock Syndrome: A Systematic Review and Meta-analysis.
1
—
—